Hims offers several products to help prevent and treat hair loss. Some are only available with a prescription. We break these products down for you in our review ... take one pill a day—but ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Founded in 2017, Hims is a telemedicine platform that offers medical services and treatments related to sexual health, hair loss, anxiety ... from a few dollars per pill to close to $1,000 ...

Zepbound, Mounjaro and liraglutide are part of the class of weight loss medications called GLP-1s, which have exploded in ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Telehealth company Hims & Hers Health (HIMS ... triggering mixed reviews from analysts about the future of its weight loss business. See what stocks are receiving Strong Buy ratings from top ...

But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...

Hims & Hers is set to continue offering weight-loss pills and personalized weight-loss support, including nutrition plans and coaching. Outside of weight-loss care, the company saw its subscriber ...

Hims & Hers (HIMS ... Yemi Okupe revealed a major shift. Future weight-loss offerings will be “primarily composed” of generic weight-loss pills and an older GLP-1 drug called liraglutide.

But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...